Connect with us

International

France launches commission to assess medical cannabis market

Published

em

The French National Agency for the Safety of Medicines and Health Products (ANSM) announced the creation of a temporary scientific committee to assess how to develop the medical cannabis market in France.

France legalized cannabis-based medicines and their use in 2013, however so far no product is legally available because the market has not developed. .

In order to determine a strategy for the French Medicinal Cannabis market, ANSM decided to create a scientific committee in charge of: 

  • Evaluate scientific data related to medical cannabis.
  • Evaluate the experiences of other countries that have implemented similar programs.
  • Analyze patient experiences and feedback in other markets.

The committee will be tasked with assessing the feasibility of creating a cannabis market for medicinal purposes, the eligible medical conditions, as well as how to access the market.

The committee, whose members are expected to be chosen soon, is expected to provide its first conclusions by the end of the year.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts

I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.

I can be contacted by email at joao.costa@cannareporter.eu

Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Events18 hours ago

CB Expo returns to Dortmund, Germany, with Intertabac from 19 to 21 September

The Cannabis Business Expo and Conference (CB Expo), hosted by Ben Arn, takes place from September 19-21, XNUMX.

Opinion20 hours ago

Australia: The meteoric rise of the medicinal cannabis market

Since 2021, Australia’s market growth has outpaced established markets such as Canada and Germany. The new data...

International20 hours ago

UK: Study finds CBD does not mitigate adverse effects of THC on brain connectivity and may even intensify them

Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are two of the most researched compounds in cannabis, often studied for their different...

Hemp3 days ago

Italian court suspends ban on CBD oils, but hemp sector protests continue across the country

Italy's embattled hemp industry demonstrated in unison yesterday to protest against the attempted...

Hemp4 days ago

Italy: Hemp Industry Fights Government Crackdown on CBD and Hemp-Derived Cannabinoids

Italy's hemp industry is facing its biggest challenge yet as the government introduces measures...

International4 days ago

Pakistan wants a regulated cannabis industry, but with a 0,3% THC limit

Pakistan is set to establish its own medicinal cannabis industry, with the National Assembly set to vote...

International1 weeks ago

Volkswagen invests in industrial hemp leather for car interiors

After brands such as Ford, BMW or Mercedes, Volkswagen has started a cooperation with the German start-up Revoltech GmbH...

International1 weeks ago

Jazz Pharmaceuticals fails Phase 3 Epidyolex clinical trial in Japan

Pharmaceutical giant Jazz recently announced that its leading cannabinoid treatment, Epidyolex, failed clinical trials...

Press Releases1 weeks ago

UK: Landlords risk breaching Equality Act over prescribed cannabis

Landlords, property managers and housing associations are currently at risk of breaching the Equality Act due to...

International1 weeks ago

USA: New York destroys four tons of cannabis products worth $63 million

City officials in New York City have incinerated more than four tons of unregulated cannabis products...